
Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a …
This study aims to investigate the role of serum cancer antigen 72-4 (CA72-4) in the diagnosis of GC in a healthy population. A total of 7757 adults who underwent upper gastrointestinal …
CA 72-4 - Lab Results explained | HealthMatters.io
CA 72-4, also known as cancer antigen 72-4, is a protein that is commonly found in high levels in the blood of individuals with certain types of cancer, most notably gastrointestinal and ovarian …
Review The application of CA72-4 in the diagnosis, prognosis, and ...
Dec 1, 2021 · The role of conventional serum tumor marker, carbohydrate antigen 72–4 (CA72-4), in assisting diagnosis, monitoring dynamic progression, and evaluating the prognosis of gastric …
CA 72-4 serum marker--a new tool in the management of ... - PubMed
Several studies focused on the potential clinical usefulness of CA 72-4 in gastrointestinal (GI) and gynecological cancer, showing a sensitivity of approximately 40% in colorectal and gastric …
Evaluation of tumor marker cancer antigen 72-4 (CA 72-4) in the ...
Mar 21, 2017 · CA72-4 is a tumor marker (TM) that has been found elevated in a variety of human adenocarcinomas, with reported sensitivities of up 50% and overall specificity of over 95%. …
Tumor-associated glycoprotein 72 - Wikipedia
Tumor-associated glycoprotein 72 (TAG-72) is a glycoprotein found on the surface of many cancer cells, including ovary, [1] [2] [3] breast, colon, [4] lung, and pancreatic cancers. [5] [6] It …
Classic tumor markers in gastric cancer. Current standards and ...
In gastric cancer, the most used tumor markers are: CA 72-4, carcinoembryonic antigen (CEA) and cancer-related antigen 19-9 (CA 19-9). Cancer-related antigen 72-4. CA 72-4 is a …
B-320 Understanding CA 72-4: Exploring False Positives in Clinical ...
Oct 2, 2024 · CA 72-4, initially identified in 1981 as an antigen reactive to murine antibodies, is a glycoprotein expressed on the cell surface of certain carcinoma cells. Its production is elevated …
The importance of CA 72-4 and CA 19-9 dosing in gastric cancer
CA 72-4 was first identified by Colcher in 1981 and has since been identified as a tumor-associated glycoprotein-72 antigen (TAG-72) in several epithelial cancers. Several recent …
The application of CA72-4 in the diagnosis, prognosis, and ... - PubMed
The role of conventional serum tumor marker, carbohydrate antigen 72-4 (CA72-4), in assisting diagnosis, monitoring dynamic progression, and evaluating the prognosis of gastric cancer …